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1. Introduction 
Bovine hypothalamic tissue contains two low 
molecular weight corticotrophin releasing factors, 
resolved by gel filtration and designated CRFr(G-15) 
and CRF*(G-15). CRFr(G-15) contains an inhibitor 
as well as a stimulator of ACTH secretion [I]. We 
now report the separation of a stimulator and a 
potentiator present in the CRFa(G-15) fraction, 
utilizing counter current distribution and the isolated 
pituitary cell system of bioassay [2]. The observa- 
tions suggest hat the hypothalamus elaborates a 
complex of oligopeptides regulating ACTH secretion 
which complex includes two secretagogues, an inhibi- 
tor and a potentiator. 
2. Materials and methods 
Fractions were assayed for corticotrophin releasing 
activity by the isolated adenohypophysial cell tech- 
nique 121. Routinely 24, but occasionally as many as 
48, aliquots of cell suspension (1.0-l .5 X 10’ cells/ 
0.9 ml aliquot) were pipetted into 10 ml teflon 
beakers. Test substances in solution, or vehicle (con- 
trols), were added in 0.1 ml to the teflon beakers 
the day before the assay and desiccated overnight. 
The cells were incubated at 37’C for 60 min in a 
Dubnoff shaker, under an atmosphere of 95% Os, 
5% COz. The media were separated by centrifugation 
(800 X g for 10 min), acidified to pH 3.5 with HCl 
and assayed for ACTH by the isolated adrenal cortex 
cell technique [3]. Fraction CRF,(G-15) is our 
interim house standard; one corticotrophin unit is 
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the activity exhibited by 5 pg of this material. Com- 
parison of unknowns with standard for each assay 
eliminates interassay variation. We recognize that 
the response to CRFs(G-15) is the result of the com- 
bined actions of at least two peptides. Decision on a 
permanent standard must await further purification, 
perhaps isolation of the involved peptides. 
One hundred pieces of bovine hypothalamic tissue 
(one batch) were carried through extraction and gel 
filtration, first on Sephadex G-25 then on Sephadex 
G-15 as follows: A batch of frozen (dry ice) tissue 
(-800 g) was pulverized and defatted with acetone. 
The powder (200 g) was extracted with 1600 ml 30% 
acetic acid and the mixture centrifuged. The super- 
natant was lyophilized, the syrup taken up in 200 ml 
0.01 M ammonium acetate and adjusted to pH 7.0 
with concentrated ammonium hydroxide. The mix- 
ture was centrifuged, the supernatant lyophilized and 
the concentrate extracted with 0.01 M ammonium 
acetate. The extract (-20 g Folin-Lowry protein) 
was applied to a Sephadex G-25 column and eluted 
with 0.01 M ammonium acetate. CRF activity eluted 
between 1200 and 1800 ml; the contents of the 
tubes in this region were pooled, lyophilized and the 
dried material extracted with 6 ml 0.2 N acetic acid. 
The mixture was centrifuged and the supernatant 
applied to a Sephadex G-15 column (2.2 X 100 cm; 
bed vol. 450 ml; void vol. 100 ml; eluted with 0.2 N 
acetic acid at 20 ml/h, 4 ml/tube). CRF activity 
located in two regions, tubes 75-81 [CRF,(G-15)] 
and tubes 90-105 [CRF,(G-15)]. 
Ten batches of hypothalamic tissue were carried 
through extraction, and gel filtration, first on 
Sephadex G-25 then Sephadex G-l 5, as above. The 
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contents of the tubes of the CRFa(G-I 5) region were 
lyophilized to dryness, pooled and taken up in 6.0 ml 
1 .O N acetic acid. A sample, 4.2 ml, representing a 
quantity of CRFs(G-15) derived from 700 pieces of 
bovine hypothalamic tissue, was applied to a Craig 
counter current apparatus (520 tubes. 3 ml phases 
of a system of 1 -butanol-1 .O N acetic acid) and 
distributed through 520 transfers. 
3. Results 
To estimate recovery of the CRF activity that 
had been applied to counter current distribution, 
small aliquots (100 4) of the aqueous phase from 
each of the 520 tubes were combined; similarly, 
aliquots of the butanol phase were combined. Assay 
of these combined aliquots indicated that 70% of 
the applied activity was present in the aqueous phase, 
-5%, in the butanol phase. This experiment was fol- 
lowed by one designed to localize CRF activity. The 
applied CRF was distributed as follows: in tubes 
56-82,6 f 2%; 83-109,5 f 2%; 110-140, <l%; 
in the regions l-55,141-190,191-244,245-298, 
299-406,407-520, no significant activity was 
detected. In the butanol phase, significant activity 
was found only in the regions 56-82 and 83-109; 
the estimated recovery was <l% for each of these 
regions. The marked differences in the recovery 
between that estimated for a pool of all 520 tubes 
vs that estimated for regions 56-82 plus 83-109 
plus 1 lo-140 prompted us to survey certain regions 
for potentiator activity. The total CRF units in the 
aqueous phase of regions 56-82 and of 83-109 
increased -lo-fold when aliquots were added to the 
cell suspension together with an aliquot of the region 
110-140. The aliquot of region 1 lo-140 (10 ~1 of 
75 ml total vol.) induced no increase in secretion of 
ACTH when added alone to the isolated cells. No 
other region of the aqueous phase exhibited poten- 
tiator activity when tested in 50 fi doses. Potentiator 
activity was present in the butanol phase of region 
1 lo-140 and exhibited by a dose of 50, but not 
10 /.d. CRF activity in individual tubes of the counter 
current distribution instrument were then assayed. 
In fig. 1, the CRF units present in selected tubes of 
the region 50-140 are presented. The total CRF 
units under the curve of best fit equalled 32, a recov- 
ery of 9% of the applied CRF units. 
When it became apparent that CRFr and poten- 
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Fig.1. Counter current distribution of fraction CRF,(G-15), 
520 transfers, 1.0 N acetic acid (3 ml) vs lbutanol(3 ml). 
CRF activity in the aqueous phase of tubes 50-140. The 
points represent estimates of total CRF units in a given tube; 
1,lO and 100 ~1 aliquots in duplicate for each of two assays 
conducted on different days; error for estimate based on the 
combination of the two assays approximately f 15%. The 
curve through the experimental points was fitted by eye. 
tiator overlapped, a pool of the contents of tubes in 
the region 120-140 (presumed to be free from CRF) 
was selected for a quantitative estimate of the influ- 
ence of potentiator upon the activity of CRF. Assay 
of the CRF activity of individual tubes in the region 
50-I 10 were conducted as described for the experi- 
ment presented in flg.2, but in this case a 10 fl ali- 
quot of a pool of the contents of tubes 120-l 40 
was added to each sample of isolated pituitary cells. 
The addition of potentiator enhanced CRF activity 
as follows: tube 67,24-fold;71, 15-fold;78, IO-fold; 
85, 1 l-fold; 91,8-fold; 96,2-fold. The observation 
points are presented in fig.2. The curve was calculated 
on the basis of a normal distribution centered about 
tube 78. We have located potentiator on the basis of 
assays of various regions; no quantitative estimates 
of the relative quantities in individual tubes have been 
made. The skewness of the curve of CRF activity 
when potentiator was not added (fig.1) is attributed 
to overlap of the two activities in the region 95-l 10. 
4. Discussion 
The asymmetry of distribution of CRF activity 
in the instance in which aliquots of the contents of 
the tubes were added alone to suspensions of isolated 
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TUBE No. 
Fig.2. Counter current distribution of fraction CRF,(G-15), 
520 transfers, 1 .O N acetic acid-l-butanol, 3 ml in both 
phases. Assay protocol as described in legend to fig.2 but in 
this instance 10 ~1 of a combination of the contents of tubes 
120-140 (aqueous phase) was added to each aliquot of the 
contents of individual tubes in the CRF region. The 10 rl 
ahquot of the combination of tubes 120-140 when added 
alone induced no increase in ACTH secretion. Aliquots 
(100 r.d) of tubes 126 and 138 added alone induced no re- 
sponse. Note the lo-fold difference in the scale of the ordinate 
as compared to that of fig.1. The continuous line is the curve 
calculated for a distribution coeticient K = 0.177, with rmax = 
13 CRF units in tube 78. The experimentally determined 
values are represented by solid circles. For the location of 
potentiator (POT.) consult the text. 
pituitary cells (fig.1) is consistent with the conclusion 
that even after 520 transfers separation of CRF and 
potentiator activities is still incomplete. The good 
agreement between calculated and found values in 
the potencies determined for individual tubes to 
which potentiator had been added indicates the 
presence of a single stimulatory entity in the region 
centered around tube 78. 
The biological activities of CRF and of potentiator 
are lost upon treatment with 6 N HCl at 110°C for 
18 h or with protease, indicating that the active mate- 
rials are peptides. CRF and a cofactor have been pre- 
pared as distinct fractions from an extract of rat 
hypothalamic tissue [4]. The cofactor, unlike poten- 
tiator, retains activity after heat (150°C) in 6 N HCl 
for 18 h. The CRF activity of a crude stalk median 
eminence extract has been ascribed to a multi-factor 
system [5]. Vasopressin is the major component 
whose potency is ‘modulated’ by synergistic factors 
which have weak inherent CRF activity. CRF,(G-15) 
and CRFJG-I 5) are chromatographically [6] and 
biologically [ 71 distinct from vasopressin. Despite 
differences as to the exact nature of stimulators, 
cofactors , modulators, potentiators, the evidence 
cited, together with these findings, should alert one 
to the possibility that loss of CRF activity following 
a purification step may be apparent rather than real. 
The physiological significance of the observations 
reported here needs some comment. The increase in 
rate of secretion of ACTH by the isolated cells in 
response to CRFr(G-15) and to CRF?(G-15) is 
energy-dependent (blunted in the absence of glucose 
from the medium), Ca2+-dependent, and inhibited 
by physiological concentrations of corticosterone 
(0.1 pg./ml). These facts rule out a toxic, lytic action 
on the plasma membrane resulting in increased per- 
meability, with non-specific release of ACTH. The 
response of the cells appears to be quite specific; a 
number of substances including luteinizing hormone 
releasing hormone (LHRH), thyrofrophin releasing 
hormone (TRH), somatostatin, angiotensin II, sero- 
tonin, glucagon, insulin, pressinoic acid, histamine, 
tryptophan, arginine, polyarginine and ACTH4_,e do 
not stimulate ACTH secretion. The material in tubes 
corresponding to the peak of biological activity in 
the counter current distribution (fig.2) induces a 
significant increase in ACTH secretion at a dose 
of -100 pg. The circumstantial evidences, taken 
together, suggest hat we are dealing with compounds 
of physiological significance. 
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